Clinical Trial Update: Phase 2b Study of EVO756 in Adults With Atopic Dermatitis [Phase 2]

View source ↗

Summary

A Phase 2b clinical trial evaluating EVO756 in adults with atopic dermatitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• EVO756

Snippet

Sponsor: Evommune, Inc. | Conditions: Atoptic Dermatitis | Phase 2 | Status: RECRUITING